The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: A case series of sixty two patients

Palliative Medicine

Volumn 21, Issue 6, 2007, Pages 473-476

  Noble, S I R ^a,b   Hood, K ^a   Finlay, I G ^a,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Cancer; Hospice; LMWH; Palliative; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADVANCED CANCER; ARTICLE; BLEEDING; CAREGIVER; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NURSE; OSTEOPOROSIS; PALLIATIVE THERAPY; RECURRENT DISEASE; SYMPTOM; VENOUS THROMBOEMBOLISM;

EID: 35448932462     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216307080816     Document Type: Article

References (18)

1. Trousseau A. Phlegmasia alba dolens. In Clinique Medicale d'Hotel-Dieu de Paris. Vol 3, JB Balliere et Fils; 1865: 654-812.
2. Bick RL. Alterations of haemostasis with malignancy. Semin Thromb Hemost 1978; 5: 1-26.
3. Hirsch J, Lee AY. How we diagnose and treat deep vein thrombosis. Blood 2002; 99(9): 3102-10.
4. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000; 18: 3078-83.
5. Prandoni P. Antithrombotic strategies in patients with cancer. Thromb Haemost 1997; 78 (suppl): 141-4.
6. Lee AY, Levine M, Baker RI et al., Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; (2): 146-53.
7. Meyer G, Marjanovic Z, Valcke J, Lorcerie B. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer. Arch Intern Med 2002; 162: 1729-35.
8. Hull RD, Pineo GE Mah AF, Burke N, Dear R, Wong T, Cook R, Solymoss S, Poon MC, Rascob G. LITE Trial Investigators. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med 2006; 119(12): 1062-72.
9. Mandala M, Falanga A, Piccioli A, Prandoni P, Pogliani EM, Labianca R, Barni S; working group AIOM. Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM). Crit Rev Oncol Hematol 2006; 59(3): 194-204.
10. Johnson MJ, Sproule MW, Paul J. The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer. Clin Oncol 1999; 11: 105-110.
11. Sproul EE. Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer 1938; 34: 566-85.
12. Ambrus JL, Ambrus CM, Pickren JW. Causes of death in cancer patients. J Med 1975; 6: 61-4.
13. Noble SIR, Finlay IG. Is long-term low molecular weight heparin an acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study. Palliat Med 2005; 19: 197-201.
14. Chambers JC. Prophylactic heparin in palliative care: ...to a challenging idea. BMJ 2006; (7543): 729.
15. Watson HG, Keeling DM, BCSH Taskforce in Haemostasis and Thrombosis. The management of heparin-induced thrombocytopenia. Br J Haematol 2006; 135(2): 269.
16. Monreal M, Zacharski L, Jimienez JA, Roncales J, Vilaesca B. Fixed-dose low-molecular-weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study. J Thromb Haemost 2004; 2(8): 1311-5.
17. Wilson EB. Probable inference, the law of succession and statistical inference. J Am Stat Assoc 1927; 22: 209-212.
18. Johnson MJ. Problems of anticoagulation within a palliative care setting: an audit of hospice patients taking warfarin. Palliat Med 1997; 11(4): 306.